Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
about
Current Role of Dacomitinib in Head and Neck Cancer.Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.Phase 1 study to investigate the pharmacokinetic properties of dacomitinib in healthy adult Chinese subjects genotyped for CYP2D6.
P2860
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@en
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@nl
type
label
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@en
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@nl
prefLabel
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@en
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@nl
P2093
P2860
P1476
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
@en
P2093
Anna Plotka
Carlo Bello
Joanna C Masters
Joseph O'Connell
Nagdeep Giri
Patricia Pardo
Tanya Boutros
Yali Liang
P2860
P2888
P304
P356
10.1007/S10637-015-0256-0
P577
2015-06-06T00:00:00Z